NALFX
Price
$74.00
Change
+$0.56 (+0.76%)
Updated
Jul 3 closing price
Net Assets
271.66M
RSLCX
Price
$68.13
Change
+$0.39 (+0.58%)
Updated
Jul 3 closing price
Net Assets
79.12B
Interact to see
Advertisement

NALFX vs RSLCX

Header iconNALFX vs RSLCX Comparison
Open Charts NALFX vs RSLCXBanner chart's image
New Alternatives A
Price$74.00
Change+$0.56 (+0.76%)
VolumeN/A
Net Assets271.66M
American Funds SMALLCAP World R3
Price$68.13
Change+$0.39 (+0.58%)
VolumeN/A
Net Assets79.12B
NALFX vs RSLCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NALFX vs. RSLCX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NALFX is a Buy and RSLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLCX has more cash in the bank: 79.1B vs. NALFX (272M). NALFX pays higher dividends than RSLCX: NALFX (1.71) vs RSLCX (0.40). NALFX was incepted earlier than RSLCX: NALFX (43 years) vs RSLCX (23 years). RSLCX (1.30) is less costly to investors than NALFX (1.03). RSLCX is a more actively managed with annual turnover of: 32.00 vs. NALFX (5.94). RSLCX has a lower initial minimum investment than NALFX: RSLCX (250) vs NALFX (2500). NALFX annual gain was more profitable for investors over the last year : 17.64 vs. RSLCX (10.07). NALFX return over 5 years is better than : 24.01 vs. RSLCX (19.16).
NALFXRSLCXNALFX / RSLCX
Total Expense Ratio1.031.3079%
Annual Report Gross Expense Ratio1.031.3079%
Fund Existence43 years23 years-
Gain YTD21.9518.440260%
Front Load4%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets272M79.1B0%
Annual Yield % from dividends1.710.40427%
Returns for 1 year17.6410.07175%
Returns for 3 years-0.8433.96-2%
Returns for 5 years24.0119.16125%
Returns for 10 years66.9841.67161%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETCHX29.770.14
+0.47%
Eventide Healthcare & Life Sciences C
FTVAX34.970.15
+0.43%
FullerThaler Behav Md-Cp Val A
REEBX59.470.13
+0.22%
American Funds EUPAC R2E
HIOCX18.260.03
+0.16%
Hartford International Opportunities C
HJIGX15.10-0.01
-0.07%
Hardman Johnston Intl Gr Fd Instl Shr